Every Pharma company has a strategy to partner. I came to this thinking this was a genuine partnership between BMS and Nox ,
but it’s not.
It’s simply an investigator initiated trial like 100s of others where the doctor in charge happens to have chosen to study this combination of drugs. BMS could also be giving him a grant as well as free drug. If they’d said no to him he’d have simply gone elsewhere. There’s no evidence that BMS and Nox have even spoken about this trial , there’s no evidence BMS are interested in veyonda (I see no quotes from BMS ) and for the media or others to imply this is some sort of joint collaboration between Nox and a big Pharma co is misleading. That said it probably does Nox no harm to be able to name drop a bit in its media releases.
- Forums
- ASX - By Stock
- BMS NOX to partner on pilot study
Every Pharma company has a strategy to partner. I came to this...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NOX (ASX) to my watchlist
|
|||||
Last
6.6¢ |
Change
-0.002(2.94%) |
Mkt cap ! $19.28M |
Open | High | Low | Value | Volume |
6.7¢ | 6.9¢ | 6.6¢ | $13.31K | 198.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1137 | 6.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.7¢ | 22400 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1137 | 0.066 |
1 | 100000 | 0.064 |
3 | 47786 | 0.061 |
4 | 105033 | 0.060 |
2 | 120000 | 0.059 |
Price($) | Vol. | No. |
---|---|---|
0.079 | 12000 | 2 |
0.080 | 12099 | 2 |
0.081 | 22345 | 2 |
0.083 | 40000 | 1 |
0.090 | 25689 | 3 |
Last trade - 15.50pm 28/06/2024 (20 minute delay) ? |
Featured News
NOX (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online